Entera Bio Ltd reports results for the quarter ended in March - Earnings Summary

Entera Bio

12/05/2022 15:15

* Entera Bio Ltd  ENTX.OQ  reported a quarterly adjusted
loss
of 13 cents​​ per share for the quarter ended in March. The mean
expectation of four analysts for the quarter was for a loss
of 18 cents per share.
    * Revenue fell 56.7% to $68.00 thousand from a year ago; 
analysts
expected $178.50 thousand. 
    * Entera Bio Ltd's reported EPS for the quarter was a loss
of 13
cents​.
    * The mean earnings estimate of analysts had fallen by
about 14%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Entera Bio Ltd shares had fallen by 30.3% this quarter and
lost 29.0% so far this year.
    * The company reported a quarterly loss of $3.78 million.
    * Wall Street's median 12-month price target for Entera Bio
Ltd is
$6.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 12 at 02:14 p.m.  ​All
figures in US dollars unless otherwise stated